Haoxi Health Technology Limited Enters into Rebate Agreement with Clients on Advertising Placement Campaign
07 May 2024 - 10:00PM
Haoxi Health Technology Limited (the “Company” or “HAO”), an online
marketing solution provider headquartered in Beijing, China, today
announced that Beijing Haoxi Digital Technology Co., Ltd. (“Haoxi
Beijing”), a wholly-owned subsidiary of the Company, entered into a
bidding data promotion rebate agreement (the “Rebate Agreement”) on
April 29, 2024 with Jinan Yanling Biotechnology Co., Ltd.
(“Yanling”) and its subsidiaries and affiliated companies
(together, the “Clients”).
Pursuant to the Rebate Agreement, Haoxi Beijing has agreed to
provide comprehensive advertising and promotion services to the
Clients, which operate in biomedical drug development, health
technologies and other healthcare-related industries. The Rebate
Agreement sets up a rebate system whereby the Clients receive a
rebate based on factors such as bidding data, industry relevance,
delivery and business models, and adherence to the Rebate
Agreement’s requirements and thresholds. The Rebate Agreement also
sets a targeted advertising placement spend of no less than RMB50
million (approximately $7 million) within the term of the Rebate
Agreement for the Clients.
Haoxi Beijing will utilize the advertising platform resources
under the umbrella of ByteDance, a technology conglomerate
globally, including Jinri Toutiao (Today’s Headlines), Douyin, and
Xigua Video. With its global appeal and extensive user base,
ByteDance’s platforms have become hotspots for short-video content,
making them ideal platforms for e-commerce businesses to showcase
their offerings. By capitalizing on ByteDance’s platforms, Haoxi
Beijing aims to help Yanling and its affiliated companies gain
heightened exposure, elevate their brand image, and expand their
market reach.
The mutually beneficial rebate arrangement between Haoxi Beijing
and the Clients allows them to enjoy a proportionate rebate on
their actual advertising expenditures across different platforms.
The accumulated rebate amount can then be reinvested to further
enhance future advertising campaigns, enabling the Clients to
access additional promotional resources and seize greater
opportunities for growth.
Mr. Zhen Fan, CEO and Chairman of the Company, commented: “HAO
is thrilled about this partnership with Yanling and its
subsidiaries and affiliated companies. By aligning with ByteDance’s
advertising platforms, HAO is poised to deliver highly efficient
and precisely targeted advertising and promotion services to these
enterprises.
“The signing of this Rebate Agreement signifies another
milestone in HAO’s continuous growth and business development
within the advertising and online marketing industry. We anticipate
a mutually rewarding partnership that will generate shared value
and contribute to the advancement of our respective business
endeavors.”
About Haoxi Health Technology Limited
Haoxi Health Technology Limited is a Beijing-headquartered
online marketing solution provider in China, specializing in
serving healthcare industry advertiser clients. The Company’s
growth is driven by the rise of news feed ads and the rapid
development of the healthcare sector. The Company offers one-stop
online marketing solutions, especially in online short video
marketing, helping advertisers acquire and retain customers on
popular platforms in China, such as Toutiao, Douyin, WeChat, and
Sina Weibo. It is dedicated to reducing costs, increasing
efficiency, and providing easy online marketing solutions to
advertisers. For more information, please visit:
http://ir.haoximedia.com.
Forward-Looking Statement
This press release contains forward-looking statements.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions
that do not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
uncertainties related to market conditions, and other factors
discussed in the “Risk Factors” section of the registration
statement filed with the SEC. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward-looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:
Investor Relations
WFS Investor Relations Inc.
Janice Wang, Managing Partner
Email: services@wealthfsllc.com
Phone: +86 13811768599
+1 628 283 9214
Haoxi Health Technology (NASDAQ:HAO)
Historical Stock Chart
From Dec 2024 to Jan 2025
Haoxi Health Technology (NASDAQ:HAO)
Historical Stock Chart
From Jan 2024 to Jan 2025